Figure 3. Expression of oligodendrocyte-specific cell type markers in F3.Olig2 cells and expression of motor neuron-specific cell type markers in F3.Olig2-Shh cells.
Image credit: Lee, 2014 under CC BY license



PRO-ACT LogoThe Pooled Resource Open-Access ALS Clinical Trials Database (PRO-ACT) houses the largest dataset of ALS clinical trials ever created. It was established by Prize4Life in partnership with the Northeast ALS Consortium (NEALS) and the Neurological Clinical Research Institute (NCRI) at Massachusetts General Hospital, with funding from the ALS Therapy Alliance.

PRO-ACT provides users with easy access to:

  • Over 10,700 fully de-identified clinical patient records
  • Placebo and treatment-arm data from 23 Phase II/III clinical trials
  • Demographic, lab, medical and family history, and other data elements
  • More than 10 million longitudinally collected data points

Launch PRO-ACT ยป



Share this: